NASDAQ NMS - GLOBAL MARKET · BMRA
+1.58% · +$0.0250 · Vol 10.0K
Market closed · last close 4:00 PM ET · price as of 15:54:50 ET
Biomerica Inc

Biomerica Inc

Health Care
$1.61
Card
Relationship Map

Veridion Score

BETALOW CONF · 5/6 factorsMethodology
Sentiment absence reason unknown
BMRA
Biomerica Inc
Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
SELL BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

44/ 100
Veridion Score
SELL BIAS · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 5/6 factors with data · Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is BMRA moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading BMRA catalysts
About Biomerica Inc
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Listed since
1978
Employees
54
Country
US

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$1.57
Day high
$1.63
Day low
$1.57
Previous close
$1.58
52W high
$3.43
-53.06% from high
52W low
$1.49
6% of range
Market cap
$5M
EPS
$-0.5700
Beta
0.37
Shares out
3.1M
Volume
10K
1.57× rel vol
Avg volume
6.4K
VWAP
$1.60
Price history computed in-house
1W
+3.21%
1M
+1.58%
3M
-34.82%
1Y
-53.60%
YTD
-36.11%
SMA 50 $1.68 · below
SMA 200 $2.15 · below
52W position 6%

BMRA overview

Veridion Score
44
Registered · 2026-08-21
5 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around BMRA.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading BMRA Form 4 filings
Public disclosures

Congress activity in BMRA

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for BMRA in the cached public ledger.

Federal contracts

BMRA contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for BMRA in this window.
Lobbying spend

BMRA lobbying filings, year to date.

Registered lobbying filings matched to Biomerica Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for BMRA in this window.
Loading news for BMRA
Analyst ratings
Sovereign unlock shows live analyst consensus for BMRA.
Options
Sovereign unlock shows live options positioning for BMRA.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.